The Mosquito Repellent Market size was estimated at USD 8.22 billion in 2025 and expected to reach USD 8.71 billion in 2026, at a CAGR of 6.16% to reach USD 12.50 billion by 2032.

The mosquito repellent market sits at the intersection of consumer health, outdoor recreation, travel, and vector-borne disease prevention. Demand is reinforced by public health guidance from the CDC and U.S. EPA, which recommend EPA-registered active ingredients such as DEET, picaridin, IR3535, oil of lemon eucalyptus/PMD, and 2-undecanone when used according to label directions.

Market growth is also supported by the persistent global burden of mosquito-borne disease. The WHO reported an estimated 249 million malaria cases and 608,000 malaria deaths in 2022, while dengue transmission has expanded across tropical and subtropical regions, increasing the relevance of topical repellents, spatial repellents, treated textiles, coils, vaporizers, and household insect control products.

The landscape is being reshaped by climate variability, urbanization, international travel, and growing consumer awareness of vector-borne diseases. Public health authorities increasingly position repellents as a practical layer of personal protection alongside nets, screens, sanitation, and community mosquito control.

Product strategy is shifting from basic insect avoidance to evidence-based protection, better skin feel, longer duration, family-friendly labeling, and reduced odor. At the same time, retail is moving toward omnichannel buying, with consumers comparing efficacy claims, active ingredients, dermatology positioning, sustainability credentials, and regulatory approvals before purchase.

Artificial intelligence is beginning to influence the mosquito repellent value chain through vector surveillance, predictive analytics, formulation screening, and demand forecasting. AI-supported models can combine weather, satellite, trap, and disease-reporting data to identify mosquito pressure and help manufacturers align inventory with seasonal outbreaks.

In product development, machine learning can support faster screening of ingredient combinations, controlled-release systems, fragrance masking, and packaging optimization. However, AI does not replace toxicology, field testing, label compliance, or regulatory review; it strengthens decision-making when paired with validated laboratory and real-world performance data.

Asia-Pacific remains a critical demand center because of dense populations, tropical climates, and recurring dengue and malaria risk across South and Southeast Asia. North America is shaped by outdoor recreation, West Nile virus awareness, tick-and-mosquito prevention routines, and strong trust in EPA-registered products.

Latin America faces sustained dengue pressure, particularly in urban areas where Aedes mosquitoes thrive in standing water. Europe is seeing higher attention to invasive mosquito species and travel-related disease prevention, while the Middle East combines expatriate mobility, tourism, and hot-weather outdoor exposure. Africa retains the strongest public health relevance, with malaria prevention supporting demand for repellents alongside insecticide-treated nets and broader vector control programs.

ASEAN markets are influenced by endemic dengue risk, tropical climates, and high use of coils, vaporizers, sprays, and topical repellents. The GCC emphasizes premium personal care, travel retail, and outdoor evening protection, supported by hot climates and high mobility.

The European Union prioritizes biocidal product compliance, safety documentation, and substantiated claims, while BRICS countries combine large populations, varied disease exposure, and expanding modern retail. G7 markets favor clinically credible, regulated, convenient formats, including picaridin and DEET-based products. NATO countries show additional demand through military, humanitarian, and field-deployment use cases where reliable mosquito protection supports operational readiness.

The United States leads with EPA-registered repellents, outdoor recreation, and CDC-backed prevention guidance, while Canada emphasizes seasonal use and regulated claims. Mexico and Brazil are more strongly linked to dengue, Zika, and chikungunya awareness, increasing demand for household and personal protection.

In Europe, the United Kingdom, Germany, France, Italy, and Spain balance travel health, summer outdoor use, and EU biocidal rules, while Russia faces seasonal regional demand. China and India represent high-volume opportunities due to population scale and mosquito-borne disease exposure; Japan and South Korea prioritize convenience, quality, and urban household formats. Australia combines outdoor lifestyles with mosquito-borne disease prevention in tropical and coastal areas.

Industry leaders should prioritize efficacy transparency, clear active-ingredient education, and claims that align with recognized regulatory standards. Brands that explain duration of protection, age-use guidance, application frequency, and compatibility with sunscreen can improve consumer trust and reduce misuse.

Manufacturers should diversify across topical, spatial, fabric-treatment, and household formats while investing in long-lasting, low-odor, skin-friendly formulations. Partnerships with retailers, travel health providers, public health campaigns, and e-commerce platforms can strengthen seasonal activation, while AI-enabled demand planning can reduce stockouts during outbreak-driven demand spikes.

This executive summary is grounded in secondary research from public health agencies, regulatory bodies, scientific literature, company disclosures, product labels, retail observations, and trade sources. Key references include WHO disease surveillance, CDC prevention guidance, U.S. EPA repellent registration information, and regional biocidal product frameworks.

Insights are synthesized through market segmentation by active ingredient, product format, distribution channel, end user, and geography. Findings are validated through triangulation of disease burden, regulatory acceptance, consumer behavior, and commercial availability to ensure practical and data-backed market interpretation.

The mosquito repellent market is evolving from a seasonal convenience category into a core component of preventive health and household protection. Verified disease burden, climate-sensitive mosquito activity, and rising consumer attention to safe, effective ingredients continue to support category resilience.

Future winners will combine regulatory credibility, proven efficacy, convenient formats, and localized go-to-market execution. Companies that invest in evidence-based innovation, AI-supported planning, and transparent consumer education are best positioned to compete across mature, emerging, and outbreak-sensitive markets.